Red wine: A drink to your heart

Journal of Cardiovascular Disease Research

Volumn 1, Issue 4, 2010, Pages 171-176

  Mohamed Saleem, T S ^a   Basha, S Darbar ^a  

^a ANNAMACHARYA COLLEGE OF PHARMACY   (India)

Author keywords

Alcohol; flavonoids; grape juice; polyphenols; resveratrol; wine research

Indexed keywords

FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; INFLAMMATION; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RED WINE; REVIEW; THROMBOCYTE AGGREGATION;

EID: 79952938641     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.74259     Document Type: Review

References (58)

1. Tarik M, Ramahi. Cardiovascular disease in the Asia Middle East Region: Global trends and local implications. Asia Pac J Public Health 2010;22:83.
2. Boni A, Lorenzoni R, Lazzari M, Gemignani C, Bovenzi F. Cardiovascular risk management: An overview. Curr News Cardiol 2007;8:407-16.
3. Reddy KS, Yusuf S. Emerging of cardiovascular disease in developing countries. Circulation 1998;97:596-601. (Pubitemid 28090690)
4. Reddy KS. Cardiovascular disease in India. World Hlth Stat 1993;46:101-7.
5. Destefano F, Merrit RK, Anda RF. Trends in coronary heart disease in the United States, 1980 through 1989. Arch Intern Med 1993;153:2489-94. (Pubitemid 23319876)
6. Begum R, Singh RB. Prevalence of CAD and its risk factors in urban population of South and North India. Acta Cardiol 1995;3:227-40.
7. Kutty RV, Balakrishnan KG, Jayashree AK, Thomas J. Prevalence of CAD in rural population of Thiruvanthapuram, Kerela, India. Int J Cardiol 1993;39:59-70. (Pubitemid 23163790)
8. WHO-World Health Organization. World Health Statistics 2009. Available from: http://www.who.int/whosis/whostat/2009/ en/index.html. [accessed on 2010 Feb 20].
9. Ranaivo HR, Diebolt M, Andriantsitohaina R. Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: Involvement of nitric oxide. Br J Pharmacol 2004;142:671-8. (Pubitemid 38969662)
10. Pechanova O, Rezzani R, Babal P, Bernatova I, Andriantsitohaina R. Benefi cial effects of Provinols™: Cardiovascular system and kidney. Physiol Res 2006;55:17-30.
11. Gresele P, Pasquale P, Anna MM, Giuseppe G, Andrea G, Stefania M, et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr 2008;138:1602-8.
12. Ames BN, Gold LS, Willet WC. Causes and prevention of cancer. Proc Natl Acad Sci USA 1995;92:5258-65.
13. Parthasarathy S. Mechanisms by which dietary antioxidants may prevent cardiovascular diseases. J Med Food 1998;1:45-51.
14. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6. (Pubitemid 26091640)
15. Heller FR, Descamps O, Hondekijn JC. LDL oxidation: Therapeutic perspectives. Atherosclerosis 1998;137:S25-31. (Pubitemid 28294204)
16. Andrade AC, Cesena FH, Consolim-Colombo FM, Coimbra SR, Benjó AM, Krieger EM, et al. Short-term red wine consumption promotes differential effects on plasma levels of high-density lipoprotein cholesterol, sympathetic activity, and endothelial function in hypercholesterolemic, hypertensive, and healthy subjects. Clinics 2009;64:435-42.
17. De Gaetano G, De Curtis A, di Castelnuovo A, Donati MB, Iacoviello L, Rotondo S. Antithrombo tic effect of polypheno ls in experi mental models: A mechani sm of reduced vascu lar risk by moderate wine con - sumption. Ann NY Acad Sci 2002;957:174-88.
18. Sarr M, Chataigneau M, Martins S, Schott C, Jasser EL, Min-Ho O, et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: Role of NADPH oxidase. Cardiovascular Research 2006;71:794-802. (Pubitemid 44848291)
19. Mombouli JV, Vanhoutte PM. Endothelial dysfunction: From physiology to therapy. J Mol Cell Cardiol 1999;31:61-74. (Pubitemid 29078219)
20. Taddei S, Virdis A, Ghiadoni L, Magagna A, Pasini AF, Garbin U. Effect of calcium antagonist or beta blockade treatment on nitric oxide -dependent vasodilation and oxidative s tress in essential hypertensive patients. J Hypertens 2001;19:1379-86. (Pubitemid 32730454)
21. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/ NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97: 1916-23.
22. Miller FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998;82:1298-305. (Pubitemid 28294749)
23. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidas ein rabbit aortic adventitia: Enhancement by angiotensin: II. Proc Natl Acad Sci USA 1997;94:14483-8. (Pubitemid 28041400)
24. Bernatova I, Pechanova O, Babal P, Kysela S, Stvrtina S, Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-defi cient hypertension. Am J Physiol Heart Circ Physiol 2002;282:H942-8. (Pubitemid 34654931)
25. Soares de Moura R, Costa Viana FS, Souza MA, Kovary K, Guedes DC, et al. Antihypertensive, vasodilator and antioxidant effects of vinifera grapeskin extract. J Pharm Pharmacol 2002;54:1515-20. (Pubitemid 35331213)
26. Rush JW, Quadrilatero J, Levy AS, Ford RJ. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med 2007;232:814-22. (Pubitemid 46827824)
27. Lopez-Sepulveda R, Rosario J, Miguel R, Maria JZ, Manuel S, Manuel GG, et al. Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats. Hypertension 2008;51:1088-95. (Pubitemid 351398987)
28. Retterstol L, Berge KE, Braaten O, Lars E, Terje R, Sandvik L. A daily glass of red wine: Does it affect markers of infl ammation? Alcohol Alcoholism 2005;40:102-5. (Pubitemid 40347336)
29. Diebolt M, Bucher B, Andriantsitohaina R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 2001;38:159-65. (Pubitemid 34224737)
30. Babal P, Danihel L, Cerna A, Janega P, Andriantsitohaina R, Pechnova O. Red Wine polyphenols prevent endothelial damage induced by CCl4 administration. Physiol Res 2006;55:245-51.
31. Hozumi T, Sugioka T, Shimada K, Kim SH, Kuo MY, Miyake Y, et al. Benefi cial effect of short term intake of red wine polyphenols on coronary microcirculation in patients with coronary artery disease. Heart 2006;92:681-2.
32. Opie LH, Lecour S. The red wine hypothesis: From concepts to protective signalling molecules. Eur Heart J 2007;28:1683-93 (Pubitemid 47227092)
33. Da Luz PL, Coimbra SR. Wine, alcohol and atherosclerosis: Clinical evidences and mechanisms. Braz J Med Bio Res 2004;37:1275-95. (Pubitemid 39206269)
34. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ. Mechanism of cardioprotection by resveratrol, a phenolic anti- oxidant present in red wine (Review). Int J Mol Med 2001;8:3-17.
35. Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 1996;27:363-6. (Pubitemid 26129194)
36. Novakovic A, Gojkovic-Bukarica L, Peric M, Nezic D, Djukanovic B, Markovic-Lipkovski J, et al. The mechanism of endothelium independent relaxation induced by the wine polyphenol resveratrol in human internal mammary artery. J Pharmacol Sci 2006;101:85-90. (Pubitemid 43765339)
37. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol attenuates ovariectomyinduced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol 2000;46:78-83. (Pubitemid 30397400)
38. Hattori R, Otani H, Maulik N, Das DK. Pharmacological pre-conditioning with resveratrol: Role of nitric oxide. Am J Physiol Heart Circ Physiol 2002;282:H1988-95. (Pubitemid 34663004)
39. Bertelli AA, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995;17:1-3.
40. Zern TL, West KL, Fernandez ML. Grape polyphenols decrease plasma triplycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J Nutr 2003;133:2268-72. (Pubitemid 36841552)
41. Jager U, Nguyen-Duong H. Relaxant effect of trans resveratrol on isolated porcine coronary arteries. Arzneimittelforschung 1999;49:207-11. (Pubitemid 29142817)
42. Zhao J, Ma HJ, Dong JH, Zhang LP, Liu HL, Wang QS. Electrophysiological effects of resveratrol on guinea pig papillary muscles. Acta Physiol Sin 2004;56:708-12.
43. Zhang LP, Ma HJ, Zhao J, Wang QS. Effects of resveratrol ondelayed after depolarization and triggered activity induced by ouabain in guinea pig papillary muscles. Acta Physiol Sin 2005;57:361-6.
44. Li M, Wang QS, Chen Y, Wang ZM, Liu Z, Guo SM. Resveratrol inhibits neuronal discharges in rat hippocampal CA1 area. Acta Physiol Sin 2005;57:355-60.
45. Zheng L, Li-Ping ZM, Hui-Jie M, Chuan W, Ming L, Qing-Shan W. Resveratrol reduces intracellular free calcium concentration in rat ventricular myocytes. Acta Physiol Sinica 2005;57:599-604.
46. Hwang J, Kwon Y, Park OJ, Kim MS. Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr 2008;2:323-6. (Pubitemid 351447706)
47. Ray PS, Gautam M, Gerald A, Cordisalberto A, Bertelli E, Das DK, et al. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radical Biol Med 1999;27:160-9. (Pubitemid 29353096)
48. Bradamante S, Livia B, Franco P, Alberto AE, Robert De J, Patricia B, et al. Resveratrol provides late-phase cardioprotection by means of a nitric oxideand adenosine-mediated mechanism. Euro J Pharmacol 2003;465:115-23. (Pubitemid 36332283)
49. Das DK, Dudley J, Das S, Mukherjee S. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending ondose. J Nutr Biochem 2009;20:443-52.
50. Shigematsu S, Huji IS, Masahide H, Naohiko T, Hironobu Y, Toshiie S, et al. Resveratrol, A red wine constituent polyphenol, prevents superoxidedependent infl ammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radical Biol Med 2003;34:810-7. (Pubitemid 36316064)
51. Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Mechanism for resveratrolinduced cardioprotection against reperfusion injury involves glycogen synthase kinase 3 β and mitochondrial permeability transition pore. Eur J Pharmacol 2009;604:111-6.
52. Guglielmone HA, Agnese AM, Montoya SC, Cabrera JL. Anticoagulant effect and action mechanism of sulphated fl avonoids from Flaveria bidentis. Thromb Res 2002;105:183-8. (Pubitemid 34214936)
53. Formica JV, Regelson W. Review of the biology of Quercetin and related biofl avonoids. Food Chem Toxicol 1995;33:1061-80. (Pubitemid 26009773)
54. Inal M, Altinisik M, Bilgin MD. The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct 2002;20:291-6. (Pubitemid 35340064)
55. Dajas F, Rivera F, Blasina F, Arredondo F, Echeverry C, Lafon L, et al. Cell culture protection and in vivo neuroprotective capacity of fl avonoids. Neurotox Res 2003;5:425-32.
56. Su JF, Guo CJ, Wei JY, Yang JJ, Jiang YG, Li YF. Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. Biomed Environ Sci 2003;16:1-8.
57. Kolchin IN, Maksiutina NP, Balanda PP, Luik AI, Bulakh VN, Moibenko AA. The cardioprotective action of quercetin in experimental occlusion and reperfusion of the coronary artery in dogs. Farmakol Toksikol 1991;54:20-23.
58. Ikizler M, Erkasap N, Sadettin D, Tugrul K, Ziya K. Dietary polyphenol quercetin protects rat hearts during reperfusion: Enhanced antioxidant capacity with chronic treatment. Anadolu Kardiyol Derg 2007;7:404-10. (Pubitemid 350303388)